Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2367-2373

  Guo, Chang Cheng ^a   Zhang, Xiao Long ^a,b   Yang, Bin ^a,b   Geng, Jiang ^a,b   Peng, Bo ^a,b   Zheng, Jun Hua ^a,b  

^a TONGJI UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Clear cell renal cell carcinoma; Dkk1; Dkk3; Wnt

Indexed keywords

DICKKOPF 1 PROTEIN; GLYCOPROTEIN; MESSENGER RNA; PROTEIN DKK3; UNCLASSIFIED DRUG; DKK1 PROTEIN, HUMAN; DKK3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 84899688736     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2077     Document Type: Article

References (41)

1. Rini BI, Campbell SC and Escudier B: Renal cell carcinoma. Lancet 373: 1119-1132, 2009.
2. Deng FM, Melamed J and Zhou M: Pathology of renal cell carcinoma. In: Renal Cancer. Libertino JA (ed). Springer New York, NY, pp51-69, 2013.
3. Vacas E, Bajo AM, Schally AV et al: Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma. Mol Cell Endocrinol 365: 212-222, 2013.
4. Escudier B, Szczylik C, Porta C and Gore M: Treatment selection in metastatic renal cell carcinoma: expert consensus. Nat Rev Clin Oncol 9: 327-337, 2012.
5. Cohen ED, Tian Y and Morrisey EE: Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135: 789-798, 2008. (Pubitemid 351524132)
6. Klaus A and Birchmeier W: Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398, 2008. (Pubitemid 351589714)
7. Veeck J and Dahl E: Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys Acta 1825: 18-28, 2012.
8. Mao B, Wu W, Li Y, et al: LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321-325, 2001. (Pubitemid 32467039)
9. Patil MA, Chua MS, Pan KH, et al: An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 24: 3737-3747, 2005. (Pubitemid 40826873)
10. Wirths O, Waha A, Weggen S, et al: Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest 83: 429-434, 2003. (Pubitemid 36351004)
11. Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K and Kataoka H: Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int J Cancer 126: 1611-1620, 2010.
12. Shizhuo W, Tao J, Shulan Z and Bing Z: The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma. Int J Biol Markers 24: 165-170, 2009.
13. González-Sancho JM, Aguilera O, García JM, et al: The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24: 1098-1103, 2005. (Pubitemid 40313887)
14. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH and Bosserhoff AK: Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25: 5027-5036, 2006.
15. Livark, KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
16. Ueno K, Hirata H, Majid S, et al: Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol Carcinog 50: 449-457, 2011.
17. Urakami S, Shiina H, Enokida H, et al: Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res 12: 6989-6997, 2006. (Pubitemid 44974494)
18. Sobin LH, Gospodarowicz MK and Wittekind C (eds): International Union Against Cancer (UICC) TNM Classification of Malignant Tumours. 7th edition. Wiley-Liss, New York, NY, pp1-336, 2009.
19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A (eds): American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 7th edition. Springer-Verlag, New York, NY, pp1-649, 2010.
20. Winer J, Jung CK, Shackel I and Williams PM: Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49, 1999. (Pubitemid 29230718)
21. Anastas JN and Moon RT: WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13: 11-26, 2013.
22. Forget MA, Turcotte S, Beauseigle D, et al: The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96: 646-653, 2007.
23. Kurose K, Sakaguchi M, Nasu Y, et al: Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 171: 1314-1318, 2004. (Pubitemid 38327602)
24. Jiang T, Huang L and Zhang S: DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer. Int J Biol Markers 28: 221-225, 2013.
25. Urakami S, Shiina H, Enokida H, et al: Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 12: 2109-2116, 2006.
26. Jin Y, Murata H, Sakaguchi M, et al: Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1. Oncol Rep 27: 695-699, 2012.
27. Niehrs C: The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13: 767-779, 2012.
28. Mikata R, Yokosuka O, Fukai K, et al: Analysis of genes upregulated by the demethylating agent 5-aza-2′-deoxycytidine in gastric cancer cell lines. Int J Cancer 119: 1616-1622, 2006. (Pubitemid 44258767)
29. Niida A, Hiroko T, Kasai M, et al: DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23: 8520-8526, 2004. (Pubitemid 39540802)
30. Hsieh SY, Hsieh PS, Chiu CT and Chen WY: Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 23: 9183-9189, 2004.
31. Fukui T, Kondo M, Ito G, et al: Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 24: 6323-6327, 2005. (Pubitemid 43080055)
32. Yue W, Sun Q, Dacic S, et al: Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 29: 84-92, 2008. (Pubitemid 351201745)
33. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J and Kypta RM: Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25: 6528-6537, 2006. (Pubitemid 44607085)
34. Abarzua F, Sakaguchi M, Takaishi M, et al: Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617-9622, 2005. (Pubitemid 41541434)
35. Mizobuchi Y, Matsuzaki K, Kuwayama K, et al: REIC/Dkk-3 induces cell death in human malignant glioma. Neuro Oncol 10: 244-253, 2008.
36. Kloten V, Becker B, Winner K, et al: Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res 15: R4, 2013.
37. Zenzmaier C, Sampson N, Plas E and Berger P: Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer. Prostate 73: 1441-1452, 2013.
38. Than SS, Kataoka K, Sakaguchi M, et al: Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma. Oncol Rep 25: 989-995, 2011.
39. Koppen A, Ait-Aissa R, Koster J, et al: Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Int J Cancer 122: 1455-1464, 2008. (Pubitemid 351294953)
40. Hoang BH, Kubo T, Healey JH, et al: Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 64: 2734-2739, 2004. (Pubitemid 38500609)
41. Barrantes Idel B, Montero-Pedrazuela A, Guadaño-Ferraz A, et al: Generation and characterization of dickkopf3 mutant mice. Mol Cell Biol 26: 2317-2326, 2006.